Latest filing published 17 Nov 2022 for Protagonist Therapeutics, Inc, €12k.
Filing timeline
BuySaleInsider track record
David Y. Liu: trading record in brief
David Y. Liu (senior executive) discloses dealings in Protagonist Therapeutics, Inc to SEC (Form 4). The record holds 9 filings, for trades running from 15 August 2018 to 16 November 2022.
The open-market record consists of 3 sales worth €58k, with no purchase. Besides market trades, the filings include 4 share grants and 2 option exercises.
Most recently, on 17 November 2022, the filings show an option exercise worth €12k in Protagonist Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Y. Liu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,767 shares@ US$0.8717.8% of flowCommon StockSEC:0001104659-22-119974:0
- 2,119 shares@ US$24.2870.8% of flowCommon StockSEC:0001104659-22-029519:0
- 10,000 shares0Common StockSEC:0001104659-22-024840:0
- 10,000 shares@ US$0.8711.4% of flowCommon StockSEC:0001104659-21-107818:0
- 3,395 shares@ US$8.85Common StockSEC:0001209191-19-045196:0
- 15,000 shares0Common StockSEC:0001209191-19-015939:0
- 810 shares@ US$8.03Common StockSEC:0001209191-19-015939:1
- 3,821 shares@ US$7.74Common StockSEC:0001209191-19-008679:0
- 25,800 shares0Common StockSEC:0001209191-18-047543:0
9 of 9 declarations
